Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
603811.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.24B
Close$
$14.15
100.2% upside
Current Fair Value
100.2% upsideUndervalued by 100.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.24 Billion |
|---|---|
| Enterprise Value | $3.22 Billion |
| Dividend Yield | $0.30 (4.24%) |
| Earnings per Share | $0.61 |
| Beta | 0.07 |
| Outstanding Shares | 444,759,743 |
Return
| Return on Equity | 12.51% |
|---|---|
| Return on Assets | 10.14% |
| Return on Invested Capital | 13.43% |
Valuation & Multiples
| P/E Ratio | 13.92 |
|---|---|
| PEG | -57.77 |
| Price to Sales | 7.07 |
| Price to Book Ratio | 2.36 |
| Enterprise Value to Revenue | 3.89 |
| Enterprise Value to EBIT | 16.16 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
604 employees
CEO: Chun Jian Zhao Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly kno...